Home > Boards > Canadian > Medical - Psychedelics > Numinus Wellness Inc (TSXV:NUMI)

Just an update for my followers... I has

Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Dewayne18 Member Profile
Followed By 5
Posts 1,120
Boards Moderated 1
Alias Born 06/17/09
160x600 placeholder
Numinus to Participate in Upcoming Investor Conferences in September 2021 PR Newswire (Canada) - 9/2/2021 9:00:00 AM
Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology PR Newswire (Canada) - 7/29/2021 6:00:00 PM
Numinus Announces Health Canada Approval of MAPS-Sponsored Open Label Study for MDMA-Assisted Therapy for PTSD PR Newswire (Canada) - 7/12/2021 8:00:00 AM
Numinus Wellness To Acquire Neurology Centre of Toronto, Plans to Create Centre for Psychedelic Neurology PR Newswire (Canada) - 7/6/2021 8:00:00 AM
Numinus Announces Grant of Stock Options PR Newswire (Canada) - 6/24/2021 7:45:00 PM
Numinus Files U.S. Provisional Patent Application for a Proprietary Rapid Production Process for Psilocybe and Other Psychoac... PR Newswire (Canada) - 6/24/2021 8:00:00 AM
Numinus Wellness Graduates to Tier 1 on the TSX Venture Exchange PR Newswire (Canada) - 6/18/2021 8:00:00 AM
Natural Drug Treatments Offer Promise, Potential as Savvy Drug Developers Recognize True Opportunities NetworkNewsWire - 5/20/2021 8:45:00 AM
Numinus Wellness Announces Key Leadership Hires to Support Rapid Growth and Innovation PR Newswire (Canada) - 5/13/2021 8:00:00 AM
Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application PR Newswire (Canada) - 5/11/2021 9:00:00 AM
Numinus Congratulates MAPS on Phase 3 Clinical Trial Demonstrating Significant Benefits of MDMA-Assisted Therapy for Severe P... PR Newswire (Canada) - 5/10/2021 11:25:00 AM
Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace Wellbeing Acquisition and Clinical Trial ... PR Newswire (Canada) - 4/29/2021 9:08:00 PM
Numinus annonce l'inscription à la cote des bons de souscription et le changement du symbole boursier pour les bons de sousc... PR Newswire (Canada) - 4/26/2021 6:00:00 AM
Numinus annonce un essai clinique de phase 1 sur l'extraction naturelle de champignons psilocybe préparée au laboratoire de... PR Newswire (Canada) - 4/26/2021 6:00:00 AM
Numinus Announces Phase 1 Clinical Trial of Natural Psilocybin Mushroom Extraction Prepared at Company Lab PR Newswire (Canada) - 4/26/2021 6:00:00 AM
Numinus Announces Listing of Warrants and Change of Trading Symbol for Previously Listed Warrants PR Newswire (Canada) - 4/26/2021 6:00:00 AM
Science Drives Surging Interest in Psychedelic Therapeutics NetworkNewsWire - 3/24/2021 8:45:00 AM
Numinus Announces Closing of $40-Million Bought Deal Financing PR Newswire (Canada) - 3/19/2021 11:15:00 AM
L'OCRCVM permet la reprise de la négociation - NUMI PR Newswire (Canada) - 3/15/2021 10:18:00 AM
IIROC Trading Resumption - NUMI PR Newswire (Canada) - 3/15/2021 10:17:00 AM
Suspension de la négociation par l'OCRCVM - NUMI PR Newswire (Canada) - 3/15/2021 9:37:00 AM
IIROC Trading Halt - NUMI PR Newswire (Canada) - 3/15/2021 9:34:00 AM
Numinus to expand state-of-the-art psychedelics research laboratory PR Newswire (Canada) - 3/9/2021 8:00:00 AM
Numinus agrandira son laboratoire de recherche ultramoderne sur les psychédéliques PR Newswire (Canada) - 3/9/2021 8:00:00 AM
Regulatory approvals place Numinus lab at the forefront of global psychedelics research PR Newswire (Canada) - 3/4/2021 8:00:00 AM
Dewayne18   Saturday, 01/23/21 12:44:44 AM
Re: None
Post # of 1 
Just an update for my followers... I has started to accumulate shares of #NUMI & #MMED after getting involved with #TRIP. The psychedelic mushroom & truffle business must be one of the hottest plays at the moment making people easy money.


Public Reply | Private Reply | Keep | Last ReadPost New MsgPrevious | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences